Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.

Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, Fu M, Ge J.

Int J Cardiol. 2012 Feb 23;155(1):33-8. doi: 10.1016/j.ijcard.2011.01.081. Epub 2011 Apr 11.

PMID:
21481482
[PubMed - indexed for MEDLINE]
2.

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL.

Am J Med. 2000 Dec 1;109(8):605-13.

PMID:
11099679
[PubMed - indexed for MEDLINE]
3.

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

Mujib M, Patel K, Fonarow GC, Kitzman DW, Zhang Y, Aban IB, Ekundayo OJ, Love TE, Kilgore ML, Allman RM, Gheorghiade M, Ahmed A.

Am J Med. 2013 May;126(5):401-10. doi: 10.1016/j.amjmed.2013.01.004. Epub 2013 Mar 16.

PMID:
23510948
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.

PMID:
19497441
[PubMed - indexed for MEDLINE]
Free Article
5.

Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.

Tsuchihashi-Makaya M, Furumoto T, Kinugawa S, Hamaguchi S, Goto K, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Hypertens Res. 2010 Mar;33(3):197-202. doi: 10.1038/hr.2009.199. Epub 2009 Dec 4.

PMID:
19960016
[PubMed - indexed for MEDLINE]
6.

The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.

Shah RV, Desai AS, Givertz MM.

J Card Fail. 2010 Mar;16(3):260-7. doi: 10.1016/j.cardfail.2009.11.007. Epub 2010 Jan 6. Review.

PMID:
20206902
[PubMed - indexed for MEDLINE]
7.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.

PMID:
16285075
[PubMed - indexed for MEDLINE]
8.

Long term prognosis of chronic heart failure: reduced vs preserved left ventricular ejection fraction.

Miyagishima K, Hiramitsu S, Kimura H, Mori K, Ueda T, Kato S, Kato Y, Ishikawa S, Iwase M, Morimoto S, Hishida H, Ozaki Y.

Circ J. 2009 Jan;73(1):92-9. Epub 2008 Dec 1.

PMID:
19043227
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.

Ezekowitz JA, Lee DS, Tu JV, Newman AM, McAlister FA.

Am J Cardiol. 2008 Jul 1;102(1):79-83. doi: 10.1016/j.amjcard.2008.02.102. Epub 2008 May 9.

PMID:
18572040
[PubMed - indexed for MEDLINE]
11.

Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function.

Philbin EF, Rocco TA Jr.

Am Heart J. 1997 Aug;134(2 Pt 1):188-95.

PMID:
9313596
[PubMed - indexed for MEDLINE]
12.

Irbesartan in patients with heart failure and preserved ejection fraction.

Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators.

N Engl J Med. 2008 Dec 4;359(23):2456-67. doi: 10.1056/NEJMoa0805450. Epub 2008 Nov 11.

PMID:
19001508
[PubMed - indexed for MEDLINE]
Free Article
13.

Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.

Meune C, Wahbi K, Duboc D, Weber S.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):368-75. doi: 10.1177/1074248410391667. Epub 2010 Dec 30. Review.

PMID:
21193681
[PubMed - indexed for MEDLINE]
15.

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.

Am Heart J. 1999 Nov;138(5 Pt 1):849-55.

PMID:
10539815
[PubMed - indexed for MEDLINE]
16.

Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.

Peltier M, Houpe D, Cohen-Solal A, Béguin M, Levy F, Tribouilloy C.

Int J Cardiol. 2007 Jun 12;118(3):363-9. Epub 2006 Oct 16.

PMID:
17049391
[PubMed - indexed for MEDLINE]
17.

Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.

Roik M, Starczewska MH, Huczek Z, Kochanowski J, Opolski G.

Acta Cardiol. 2008 Dec;63(6):683-92.

PMID:
19157162
[PubMed - indexed for MEDLINE]
18.

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text.

PMID:
15520426
[PubMed - indexed for MEDLINE]
19.

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN; Val-HeFT Investigators (Valsartan Heart Failure Trial).

J Am Coll Cardiol. 2002 Oct 16;40(8):1414-21.

PMID:
12392830
[PubMed - indexed for MEDLINE]
20.

Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).

Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie BM.

Circ Heart Fail. 2011 Jan;4(1):27-35. doi: 10.1161/CIRCHEARTFAILURE.109.932996. Epub 2010 Nov 10.

PMID:
21068341
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk